HomeAbout UsContact Us
Advanced Search
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
Your Payment History
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Accreditation
State Requirements
FAQs
 
Home : Advanced Search : Course view






This course is no longer active as of 2012-08-01

Course: Atypical Antipsychotics from a Primary Care Perspective 


Specialty: Primary Care Format: Text 
Course #: 9172  Price: $35.00  
Release date: 2010-08-01  Valid through: 2012-08-01  
Publication: This activity originally appeared in Primary Care Reports (2010). 
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)


Target Audience:
This activity is intended for primary care and family practice physicians.
Sponsor:
This activity is sponsored by AHC Media.
Accreditation Statement:
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Primary Care Reports has been reviewed and is acceptable for up to 2.25 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.
Faculty

Editor
Gregory R. Wise, MD, FACP
Associate Professor of Medicine
Wright State University
Dayton, OH;
Vice President, Medical Affairs
Kettering Medical Center
Kettering, OH

Editorial Group Head
Russell Underwood

Specialty Editor
Shelley Mark

Peer Reviewer
Douglas S. Lehrer, MD
Associate Professor of Psychiatry
Wright State University Boonshoft School of Medicine
Dayton, OH.

Authors
Christopher C. White, MD, JD, FCLM
Assistant Professor of Psychiatry and Family Medicine
University of Cincinnati College of Medicine
Cincinnati, OH.

Patricia R. Wigle, PharmD, BCPS
Associate Professor of Pharmacy Practice and Administrative Sciences
University of Cincinnati James L. Winkle College of Pharmacy
Cincinnati, OH.

Matthew R. Tubb, MD, PhD
The Christ Hospital
University of Cincinnati Family Medicine Residency Program
Cincinnati, OH.

Leslie A. Deckter, MD
Department of Psychiatry & Behavioral Neuroscience Residency Program
University of Cincinnati, OH.

Shelly M. Rosser, PharmD
University of Cincinnati James L. Winkle College of Pharmacy
Cincinnati, OH.

Zachary D. Denka, BA
University of Cincinnati College of Medicine
Cincinnati, OH.



Subjects:
  • Atypical Antipsychotics from a Primary Care Perspective
 
Objectives:
  • Summarize the most recent significant primary care medicine-related studies
  • Discuss up-to-date information on all aspects of primary care, including new drugs, techniques, equipment, trials, studies, books, teaching aids, and other information pertinent to primary care
  • Evaluate the credibility of published data and recommendations
  • Describe the pros and cons of new testing procedures
 
Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Gregory R. Wise, MD, FACP (editor) serves on the speaker’s bureau for The Medicines Company. Christopher C. White, MD, JD, FCLM (author), Patricia R. Wigle, PharmD, BCPS (author), Matthew R. Tubb, MD, PhD (author), Leslie A. Deckter, MD (author), Shelly M. Rosser, PharmD (author), Zachary D. Denka, BA (author), Douglas S. Lehrer, MD (peer reviewer), Russ Underwood (executive editor), and Shelley Mark (specialty editor) report no relationships with companies related to the field of study covered by this CME activity.

Copyright 2010 AHC Media. All rights reserved.


 
This course is no longer available to take.